LifeCuff Technologies Inc. has developed a proprietary platform that enables unique programming for 3 devices. One will meet a significant unmet need of the US military and 2 will dramatically improve outcomes from ischemic disorders, such as heart attack, diabetic wounds & stroke, by automating & personalizing Remote Ischemic Conditioning, a non-invasive adjunct therapy shown to be safe & effective. $5.4B green field market. Proven team.